Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936984 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.
A Phase 1 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT04936984 is a Phase 1 study that has completed, run by Radius Health. The registered enrollment target is 36 participants.
The verdict
NCT04936984, a Phase 1 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
A study to evaluate the bioequivalence of abaloparatide between 2 abaloparatide-sMTS treatments 300 μg treatments applied to the thigh for 5 minutes.
Interventions
- COMBINATION_PRODUCT abaloparatide-sMTS (Patheon)
- COMBINATION_PRODUCT abaloparatide-sMTS (Kindeva)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-08-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04936984
The ClinicalTrials.gov registry entry for NCT04936984 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radius Health, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which abaloparatide-sMTS (Patheon) is the first listed.
NCT04936984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04936984 about?
NCT04936984 is a clinical study titled "Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.". A study to evaluate the bioequivalence of abaloparatide between 2 abaloparatide-sMTS treatments 300 μg treatments applied to the thigh for 5 minutes.
What is the current status of trial NCT04936984?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2020-11-16. Estimated completion is 2021-08-13.
What interventions are being tested in trial NCT04936984?
The interventions under investigation include: abaloparatide-sMTS (Patheon) (COMBINATION_PRODUCT), abaloparatide-sMTS (Kindeva) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04936984?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.